首页> 外文期刊>Cell Biology and Toxicology >Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
【24h】

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins

机译:响应诱导物,在mRNA水平和CYP活性上表征原代人肝细胞,HepG2细胞和HepaRG细胞及其对检测人肝毒素的预测性

获取原文
获取原文并翻译 | 示例
           

摘要

In the pharmaceutical industry, improving the early detection of drug-induced hepatotoxicity is essential as it is one of the most important reasons for attrition of candidate drugs during the later stages of drug development. The first objective of this study was to better characterize different cellular models (i.e., HepG2, HepaRG cells, and fresh primary human hepatocytes) at the gene expression level and analyze their metabolic cytochrome P450 capabilities. The cellular models were exposed to three different CYP450 inducers; beta-naphthoflavone (BNF), phenobarbital (PB), and rifampicin (RIF). HepG2 cells responded very weakly to the different inducers at the gene expression level, and this translated generally into low CYP450 activities in the induced cells compared with the control cells. On the contrary, HepaRG cells and the three human donors were inducible after exposure to BNF, PB, and RIF according to gene expression responses and CYP450 activities. Consequently, HepaRG cells could be used in screening as a substitute and/or in complement to primary hepatocytes for CYP induction studies. The second objective was to investigate the predictivity of the different cellular models to detect hepatotoxins (16 hepatotoxic and 5 nonhepatotoxic compounds). Specificity was 100% with the different cellular models tested. Cryopreserved human hepatocytes gave the highest sensitivity, ranging from 31% to 44% (depending on the donor), followed by lower sensitivity (13%) for HepaRG and HepG2 cells (6.3%). Overall, none of the models under study gave desirable sensitivities (80-100%). Consequently, a high metabolic capacity and CYP inducibility in cell lines does not necessarily correlate with a high sensitivity for the detection of hepatotoxic drugs. Further investigations are necessary to compare different cellular models and determine those that are best suited for the detection of hepatotoxic compounds.
机译:在制药工业中,改善药物引起的肝毒性的早期检测至关重要,因为这是在药物开发后期阶段候选药物消耗的最重要原因之一。这项研究的首要目标是在基因表达水平上更好地表征不同的细胞模型(即HepG2,HepaRG细胞和新鲜的原代人肝细胞),并分析其代谢性细胞色素P450的能力。细胞模型暴露于三种不同的CYP450诱导剂; β-萘黄酮(BNF),苯巴比妥(PB)和利福平(RIF)。 HepG2细胞在基因表达水平上对不同诱导剂的反应非常弱,与对照细胞相比,这在诱导细胞中通常转化为低CYP450活性。相反,根据基因表达反应和CYP450活性,在暴露于BNF,PB和RIF后,可诱导HepaRG细胞和三个人类供体。因此,HepaRG细胞可用于筛选和/或补充CYP诱导研究的原代肝细胞。第二个目的是研究不同细胞模型检测肝毒素(16种肝毒性和5种非肝毒性化合物)的可预测性。对于测试的不同细胞模型,特异性为100%。冷冻保存的人肝细胞的敏感性最高,范围为31%至44%(取决于供体),其次是HepaRG和HepG2细胞的敏感性较低(13%)(6.3%)。总体而言,所研究的模型均未给出理想的灵敏度(80-100%)。因此,细胞系中的高代谢能力和CYP诱导性不一定与检测肝毒性药物的高灵敏度相关。为了比较不同的细胞模型并确定最适合检测肝毒性化合物的模型,需要进行进一步的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号